This activity is expired and is no longer available for CME credit.


Retina Unplugged: Next Generation Therapy and Imaging Technology for Wet Age-related Macular Degeneration and Diabetic Macular Edema

Author(s)/Faculty: Carmen A. Puliafito, MD, MBA ; Sophie J. Bakri, MD; Jay S. Duker, MD; Peter K. Kaiser, MD; Andrew A. Moshfeghi, MD, MBA; SriniVas R. Sadda, MD
Release Date: 3/29/2016Expiration Date: 3/28/2017
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Age-related macular degeneration (AMD) is a pathological aging of the macula, brought about by the interaction of genetic and environmental factors. It induces geographic atrophy of the retina and/or choroidal neovascularization. In the latter, abnormal vessels develop from the choriocapillaris, with the involvement of VEGF (vascular endothelial growth factor). Although monotherapy with anti-VEGF agents has become the gold standard for AMD therapy, there is a great deal of variation in the treatment approach. The treatment of diabetic macular edema (DME) has recently undergone a paradigm shift. All currently available drug therapies for DME are either anti-VEGF agents or corticosteroids. In this activity, leading ophthalmologists will discuss the safety and efficacy of emerging targeted treatments as well as new methods of drug delivery for the management of wet AMD and DME.